25 May 2026
Letter
Why A 2+1 Schedule For PCV20 Is The Smart Choice — Dr Musa Mohd Nordin, Dr Zulkifli Ismail & Dr David Ng
Public health policy should be guided not only by licensing pathways, but also by evolving immunological and real-world effectiveness data.